Study of Cladribine+Venetoclax After Failure of Venetoclax+Hypomethylating Agent in Monocytic AML
Latest Information Update: 07 Jan 2025
At a glance
- Drugs Azacitidine (Primary) ; Cladribine (Primary) ; Venetoclax (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
Most Recent Events
- 05 Sep 2024 Status changed from not yet recruiting to recruiting.
- 05 Feb 2024 New trial record